SHREEJU SHRESTHA: Open Payments
NPI 1548618002 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 48 payments from 8 companies in 2025. Trend: 2023 $942 · 2024 $869 · 2025 $1,130
Food & beverage: $1,063Education: $68
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $610 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $249 |
| Janssen Biotech, Inc. | 5 | $95 |
| Ardelyx, Inc. | 2 | $57 |
| Lilly USA, LLC | 2 | $49 |
| Madrigal Pharmaceuticals | 1 | $28 |
| PFIZER INC. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $20 |
Products named: RINVOQ, SKYRIZI, ENTYVIO, CREON, TREMFYA, GATTEX, IBSRELA, OMVOH.
Industry payments across TX — which companies pay providers there.
